IJDDC

Loading...

IJDDC

IJDDC

International Journal Diabetes in Developing Countries

April - June, 2025 • Vol. 45 • # 2

RSSDI white paper on diabetes: current status, challenges, and future vision

India is currently facing a diabetes epidemic. Recent data from the ICMR-INDIAB study estimates that over 101 million Indians live with diabetes, with an additional 136 million in the prediabetes stage.

Rationality over convenience: The CDSCO’s regulatory ban on irrational antidiabetic fixed-dose combinations in India and its clinical- pharmacological imperatives

Fixed-dose combinations (FDCs) have become a mainstay in managing type 2 diabetes in India, offering potential benefits such as simplified regimens, improved adherence, and better glycemic control.

Continuous glucose monitoring data for artificial intelligence-based predictive glycemic event: A potential aspect for diabetic care

Diabetes mellitus is a chronic metabolic disorder that affects 537 million of the population worldwide whereby continuous glucose monitoring (CGM) has been implemented in the management of diabetes.

Associations between triglyceride-glucose index and risk of diabetic kidney disease progression in type 2 diabetes mellitus

Pending connections exist between the TyG index and the risk assessment of diabetic kidney disease (DKD), which includes glomerular filtration rate and urine albumin to creatinine ratio. DKD progression risk and the TyG index were examined in this study.

Safety and efficacy of dapagliflozin in patients with type 2 diabetes mellitus during fasting in the month of Ramadan: an experience from tertiary care hospital

The data regarding the safety and efficacy of dapagliflozin during fasting is lacking especially in Pakistan. So, the current study aimed to explore the safety and efficacy of dapagliflozin in minimizing the episodes of hypoglycemia during fasting and reducing the HbA1c.

The association of fasting and postprandial GIP and glucagon levels with glycemic variability evaluated by flash glucose monitoring system in type 1 diabetes

This study is to explore the relationship between serum fasting and postprandial glucose-dependent insulinotropic polypeptide (GIP) and glucagon levels and glycemic variability in type 1 diabetes (T1D).

An alpha-test of Diabetology.co.in-an algorithm-driven personalized and precision medicine prescription system for treatment-naive patients with type 2 diabetes

This study evaluates Diabetology.co.in, an innovative algorithm-driven prescription system developed for personalized and precision treatment of treatment-naive patients with type 2 diabetes. It focuses on integrating computational medicine with clinical practice, leveraging artificial intelligence for optimized diabetes management.

Prevalence of genitourinary symptoms in people with type 2 diabetes initiated with SGLT2 inhibitors

Sodium glucose co-transporter-2 (SGLT2) inhibitors prevent the kidneys from reabsorbing glucose from the urine. In addition to glucose-lowering effect, SGLT2 inhibitors can also reduce blood pressure and result in weight loss. In spite of the benefits of this drug, it predisposes patients to genitourinary tract infections.

A retrospective study on the prevalence of erectile dysfunction among Indians with T2DM using single-question self-reporting method and its association with diabetes complications and CV risk factors

Erectile dysfunction (ED) is a prevalent complication of Diabetes Mellitus (DM) globally. However, there are lack of comprehensive studies on the association of ED with DM comorbidities and complications, especially among the Indian population.

Prevalence and risk factors of poor glycemic control and diabetic nephropathy among patients with type 2 diabetes mellitus in Dhamar, Yemen

Glycemic control is a significant step in reducing diabetic complications. The purpose of this study was to determine the prevalence and risk factors for poor glycemic control and diabetic nephropathy in patients with type 2 diabetes mellitus (T2DM) in Dhamar, Yemen.

The effect of oral consumption of sesame oil on anthropometric, metabolic and oxidative stress markers of patients with type 2 diabetes: a double-blind, randomized controlled trial

Sesame oil has several polyphenols with possible anti-diabetic and antioxidative characteristics. However, there is limited evidence for the efficacy of sesame oil on type 2 diabetes mellitus (T2DM) consequences

Herbal tea used globally targeting metabolic syndrome: A systematic review

Metabolic syndrome (MetSyn) is a cluster of metabolic constellations which includes hypertension, central obesity, insulin resistance and atherogenic dyslipidaemia. MetSyn is a group of interconnected risk factors linked to diabetes, cancer, stroke and other comorbidities.

Healthy lifestyle index development and its association with type 2 diabetes mellitus status among teachers

Type 2 diabetes mellitus (T2DM) is a significant health concern and imposes a substantial burden on society. Although leading a healthy lifestyle is an effective means of reducing the risk of T2DM, the complex interplay of diverse lifestyle factors necessitates a comprehensive assessment.

A Sri Lankan pilot case-control study on gestational diabetes mellitus: oxidative stress and a potential diagnostic marker panel

Oxidative stress is suggested as a potential contributary factor for feto-maternal complications in gestational diabetes mellitus (GDM) and the understanding of oxidative stress and antioxidant levels in GDM still remains obscure.

Comprehensive gene expression analysis of histone deacetylases and the transcription factor Nrf2 in the progression of diabetic nephropathy

Nuclear factor erythroid-2-related factor 2 (Nrf2) is a crucial transcription factor in maintaining cellular homeostasis. The regulation of Nrf2 expression is an essential target for treating diabetic nephropathy (DN), and this regulation has been reported to be influenced by epigenetics.

The effect of 8 weeks of endurance and resistance exercises on the serum levels of FGF23 and s-Klotho in type 2 diabetic women

We evaluated the effects of 8 weeks of endurance and resistance training on serum levels of fibroblast growth factor 23 (FGF23), soluble klotho (s-Klotho), 1,25-dihydroxyvitamin D (VitD), and diabetes biomarkers in overweight/obese postmenopausal type 2 diabetic (T2DM) women

Plasminogen activator inhibitor-1 levels in prior gestational diabetes mellitus: A systematic review and meta-analysis

Conflicting results on the association of plasminogen activator inhibitor-1 (PAI-1) with prior gestational diabetes mellitus (pGDM) have been observed among studies that imply the need to perform a meta-analysis.

Role of stanniocalcin-1 and proenkephalin-A as novel biomarkers in prediction of newly diagnosed type 2 diabetic patients

Diabetes mellitus is a chronic metabolic disorder that carries substantial implications for health, social well- being, and economic factors. Stanniocalcin-1 STC-1 is a polypeptide hormone that was initially distinguished as a controller of calcium/phosphate homeostasis in the fish.

Novel pleiotropic variants associated with type 2 diabetes and polycystic ovary syndrome detected using a pleiotropic cFDR method

Genome-wide association studies (GWASs) on polycystic ovary syndrome (PCOS) and type 2 diabetes (T2D) are usually conducted as single trait, rather than a simultaneous analysis of the related traits. Therefore, the overlapping genetic mechanisms underlying those traits were largely unknown.